RDN-2150

N/A

Report date: 2023/08/22 17:04:11
NME

Base Information

Drug NameRDN-2150
Drug Alias NameRDN2150RDN-2150
ClassificationSmall molecules
Mechanisms of ActionTyrosine-protein kinase ZAP-70 inhibitors
TargetsTyrosine-protein kinase ZAP-70
Therapy Area/IndicationsPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
Inactive CompaniesN/A
Active IndicationsPsoriasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A